703 Single Cell Analysis of Phase II Study of Nivolumab and Relatlimab in Metastatic Uveal Melanoma Reveals Tumor and Immune Response to Dual PD-1 and LAG-3 Inhibition
Regular and Young Investigator Award Abstracts（2023）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要